What is LINEAGE INC's earnings per share (EPS)?

LINEAGE INC (LINE) reported diluted earnings per share of -$0.43 for fiscal year 2025. This represents a 88.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

LINEAGE INC Financials

LINE

FY2025 annual

Revenue $5.4B +0.3% YoY

Net Income -$113.0M +85.0% YoY

EPS (Diluted) -$0.43 +88.4% YoY

Free Cash Flow $196.0M +1533.3% YoY

Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE December

LINEAGE INC (LINE) reported $5.4B in revenue for fiscal year 2025, up 0.3% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI LINE FY2025 2026-05-06

Lineage is an asset-heavy cash generator where depreciation, interest, and recurring reinvestment suppress reported earnings.

With revenue stuck near $5.3B, operating cash flow reached $943M, showing the business can improve cash generation without top-line help because cash comes from running a large fixed asset base efficiently. Yet free cash flow was only $196M because capital intensity stayed high, and $895M of depreciation plus heavy interest kept net income negative.

The return to positive operating income happened with revenue essentially unchanged, so the rebound looks like a cost and financing reset rather than a demand surge. Interest expense dropped to $256M from $426M, which explains why the net loss narrowed so sharply even though margins remained thin.

The balance sheet is workable but not cushioned: the current ratio was 0.8x and cash only $66M, so short-term obligations depend heavily on ongoing cash generation rather than idle liquidity. Leverage is lower than it was in FY2023, but liabilities still stood at $9.9B, leaving less balance-sheet slack than the revenue line alone suggests.

Financial Health Signals

Financial Health Score 36/100

Scored as: REITs peer group

Scored against REITs for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of LINEAGE INC's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

FFO Margin

FFO Growth

Leverage

Interest Cov.

AFFO Margin

Dividend Cov.

Altman Z-Score Distress

0.68

LINEAGE INC scores 0.68, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($9.5B) relative to total liabilities ($9.9B). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral

4/9

LINEAGE INC passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Mixed

N/A

LINEAGE INC reported a net loss of $113.0M while generating $943.0M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk

0.71x

LINEAGE INC earns $0.71 in operating income for every $1 of interest expense ($181.0M vs $256.0M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$5.4B

YoY+0.3%

LINEAGE INC generated $5.4B in revenue in fiscal year 2025. This represents an increase of 0.3% from the prior year.

EBITDA

$1.1B

YoY+108.9%

LINEAGE INC's EBITDA was $1.1B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 108.9% from the prior year.

Net Income

-$113.0M

YoY+85.0%

LINEAGE INC reported -$113.0M in net income in fiscal year 2025. This represents an increase of 85.0% from the prior year.

EPS (Diluted)

-$0.43

YoY+88.4%

LINEAGE INC earned -$0.43 per diluted share (EPS) in fiscal year 2025. This represents an increase of 88.4% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$196.0M

YoY+1533.3%

LINEAGE INC generated $196.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 1533.3% from the prior year.

Cash & Debt

$66.0M

YoY-61.8%

LINEAGE INC held $66.0M in cash against $6.1B in long-term debt as of fiscal year 2025.

Dividends Per Share

$2.11

YoY+131.9%

LINEAGE INC paid $2.11 per share in dividends in fiscal year 2025. This represents an increase of 131.9% from the prior year.

Shares Outstanding

227M

YoY-0.5%

LINEAGE INC had 227M shares outstanding in fiscal year 2025. This represents a decrease of 0.5% from the prior year.

Margins & Returns

Gross Margin

32.1%

YoY-0.9pp

LINEAGE INC's gross margin was 32.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 0.9 percentage points from the prior year.

Operating Margin

3.4%

YoY+10.1pp

LINEAGE INC's operating margin was 3.4% in fiscal year 2025, reflecting core business profitability. This is up 10.1 percentage points from the prior year.

Net Margin

-2.1%

YoY+11.9pp

LINEAGE INC's net profit margin was -2.1% in fiscal year 2025, showing the share of revenue converted to profit. This is up 11.9 percentage points from the prior year.

Return on Equity

-1.4%

YoY+7.3pp

LINEAGE INC's ROE was -1.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 7.3 percentage points from the prior year.

Capital Allocation

Share Buybacks

$82.0M

YoY+95.2%

LINEAGE INC spent $82.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 95.2% from the prior year.

Capital Expenditures

$747.0M

YoY+8.1%

LINEAGE INC invested $747.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 8.1% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

LINE Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

LINE annual income statement

Metric	TTM	FY25	FY24	FY23	FY22
Revenue	$5.4B	$5.4B+0.3%	$5.3B0.0%	$5.3B+8.4%	$4.9B
Cost of Revenue	$3.7B	$3.6B+1.6%	$3.6B-0.3%	$3.6B+3.4%	$3.5B
Gross Profit	$1.7B	$1.7B-2.3%	$1.8B+0.6%	$1.8B+20.4%	$1.5B
SG&A Expenses	$556.0M	$574.0M+6.5%	$539.0M+7.4%	$502.0M+25.8%	$399.0M
Operating Income	$192.0M	$181.0M+150.1%	-$361.0M-190.7%	$398.0M+34.0%	$297.0M
Interest Expense	$268.0M	$256.0M-39.9%	$426.0M-16.3%	$509.0M+81.1%	$281.0M
Income Tax	$0	-$2.0M+97.8%	-$89.0M-535.7%	-$14.0M-333.3%	$6.0M
Net Income	-$182.0M	-$113.0M+85.0%	-$751.0M-875.3%	-$77.0M-22.2%	-$63.0M
EPS (Diluted)	—	-$0.43+88.4%	-$3.70	-$0.73-43.1%	-$0.51

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$1.4B+4.9%	$1.3B-2.9%	$1.3B-3.0%	$1.4B+2.0%	$1.4B+4.5%	$1.3B-3.5%	$1.3B+0.3%	$1.3B
Cost of Revenue	$936.0M+6.4%	$880.0M-2.9%	$906.0M-2.8%	$932.0M+1.3%	$920.0M+5.0%	$876.0M-3.3%	$906.0M+1.0%	$897.0M
Gross Profit	$425.0M+1.9%	$417.0M-3.0%	$430.0M-3.4%	$445.0M+3.5%	$430.0M+3.4%	$416.0M-3.9%	$433.0M-1.1%	$438.0M
SG&A Expenses	$138.0M-2.1%	$141.0M+6.8%	$132.0M-9.0%	$145.0M+1.4%	$143.0M-7.1%	$154.0M+6.2%	$145.0M+1.4%	$143.0M
Operating Income	$54.0M+50.0%	$36.0M-46.3%	$67.0M+91.4%	$35.0M+52.2%	$23.0M-58.9%	$56.0M+366.7%	-$21.0M+95.9%	-$515.0M
Interest Expense	$68.0M+4.6%	$65.0M-4.4%	$68.0M+1.5%	$67.0M+4.7%	$64.0M+12.3%	$57.0M-3.4%	$59.0M-32.2%	$87.0M
Income Tax	-$1.0M-125.0%	$4.0M+128.6%	-$14.0M-227.3%	$11.0M+257.1%	-$7.0M-187.5%	$8.0M+119.5%	-$41.0M+8.9%	-$45.0M
Net Income	-$29.0M+37.0%	-$46.0M-557.1%	-$7.0M+93.0%	-$100.0M-1566.7%	-$6.0M	$0+100.0%	-$158.0M+67.4%	-$485.0M
EPS (Diluted)	-$0.13+27.8%	-$0.18	N/A	-$0.44-1366.7%	-$0.03-400.0%	$0.01	N/A	-$2.44

Not reported in any period shown, so not listed: R&D Expenses.

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

LINE Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

LINE annual balance sheet

Metric	FY25	FY24	FY23	FY22
Total Assets	$19.2B+2.8%	$18.7B-1.1%	$18.9B	N/A
Current Assets	$1.2B-3.6%	$1.3B+2.3%	$1.3B	N/A
Cash & Equivalents	$66.0M-61.8%	$173.0M+154.4%	$68.0M-66.3%	$202.0M
Inventory	$145.0M-22.5%	$187.0M+9.4%	$171.0M	N/A
Accounts Receivable	$896.0M+8.5%	$826.0M-9.5%	$913.0M	N/A
Goodwill	$3.5B+3.8%	$3.3B-1.6%	$3.4B+2.7%	$3.3B
Total Liabilities	$9.9B+10.9%	$9.0B-30.2%	$12.8B	N/A
Current Liabilities	$1.5B+3.7%	$1.5B+9.4%	$1.4B	N/A
Long-Term Debt	$6.1B+24.5%	$4.9B-45.2%	$9.0B	N/A
Total Equity	$8.2B-4.5%	$8.6B+71.0%	$5.1B-13.0%	$5.8B
Retained Earnings	-$2.4B-31.5%	-$1.9B-111.0%	-$879.0M	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$18.9B-0.8%	$19.0B-0.7%	$19.2B-0.1%	$19.2B-1.3%	$19.4B+3.6%	$18.8B+0.6%	$18.7B-3.1%	$19.3B
Current Assets	$1.2B-1.7%	$1.3B+1.9%	$1.2B-3.4%	$1.3B-4.9%	$1.3B-3.0%	$1.4B+8.2%	$1.3B-19.6%	$1.6B
Cash & Equivalents	$58.0M-13.4%	$67.0M+1.5%	$66.0M-12.0%	$75.0M-8.5%	$82.0M-58.4%	$197.0M+13.9%	$173.0M-57.7%	$409.0M
Inventory	$122.0M-10.9%	$137.0M-5.5%	$145.0M-13.2%	$167.0M-4.0%	$174.0M-0.6%	$175.0M-6.4%	$187.0M+6.9%	$175.0M
Accounts Receivable	$920.0M+0.3%	$917.0M+2.3%	$896.0M+4.6%	$857.0M-3.8%	$891.0M+5.2%	$847.0M+2.5%	$826.0M-8.3%	$901.0M
Goodwill	$3.4B-0.3%	$3.4B-0.8%	$3.5B-0.2%	$3.5B-0.9%	$3.5B+3.7%	$3.4B+1.2%	$3.3B-3.1%	$3.4B
Total Liabilities	$10.0B+0.3%	$10.0B+0.5%	$9.9B+1.3%	$9.8B+0.3%	$9.8B+7.2%	$9.1B+1.7%	$9.0B-1.8%	$9.1B
Current Liabilities	$1.6B+6.7%	$1.5B-3.7%	$1.5B+19.9%	$1.3B-8.4%	$1.4B+0.4%	$1.4B-5.9%	$1.5B-0.1%	$1.5B
Long-Term Debt	$6.2B-0.6%	$6.3B+2.5%	$6.1B+3.1%	$5.9B+3.3%	$5.7B+11.8%	$5.1B+4.6%	$4.9B-1.0%	$5.0B
Total Equity	$7.9B-2.4%	$8.1B-1.9%	$8.2B-1.6%	$8.4B-2.9%	$8.6B+0.6%	$8.6B-0.6%	$8.6B-4.3%	$9.0B
Retained Earnings	-$2.8B-5.8%	-$2.6B-6.9%	-$2.4B-4.9%	-$2.3B-10.6%	-$2.1B-6.4%	-$2.0B-6.5%	-$1.9B-11.6%	-$1.7B

LINE Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

LINE annual cash flow statement

Metric	TTM	FY25	FY24	FY23	FY22
Operating Cash Flow	$987.0M	$943.0M+34.1%	$703.0M-11.7%	$796.0M+58.9%	$501.0M
Capital Expenditures	$743.0M	$747.0M+8.1%	$691.0M-9.8%	$766.0M-5.8%	$813.0M
Free Cash Flow	$244.0M	$196.0M+1533.3%	$12.0M-60.0%	$30.0M+109.6%	-$312.0M
Investing Cash Flow	-$635.0M	-$1.1B-16.1%	-$919.0M+13.8%	-$1.1B+55.0%	-$2.4B
Financing Cash Flow	-$374.0M	$14.0M-95.6%	$320.0M+135.3%	$136.0M-92.6%	$1.8B
Dividends Paid	$538.0M	$537.0M+129.5%	$234.0M+408.7%	$46.0M-74.4%	$180.0M
Share Buybacks	N/A	$82.0M+95.2%	$42.0M+250.0%	$12.0M	$0

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	$311.0M+139.2%	$130.0M-58.9%	$316.0M+37.4%	$230.0M-10.9%	$258.0M+85.6%	$139.0M-45.9%	$257.0M+38.2%	$186.0M
Capital Expenditures	$125.0M-32.4%	$185.0M-22.3%	$238.0M+22.1%	$195.0M+19.6%	$163.0M+7.9%	$151.0M-26.3%	$205.0M+34.0%	$153.0M
Free Cash Flow	$186.0M+438.2%	-$55.0M-170.5%	$78.0M+122.9%	$35.0M-63.2%	$95.0M+891.7%	-$12.0M-123.1%	$52.0M+57.6%	$33.0M
Investing Cash Flow	-$122.0M+25.6%	-$164.0M+2.4%	-$168.0M+7.2%	-$181.0M+68.8%	-$580.0M-320.3%	-$138.0M+64.0%	-$383.0M-177.5%	-$138.0M
Financing Cash Flow	-$198.0M-650.0%	$36.0M+122.8%	-$158.0M-192.6%	-$54.0M-126.3%	$205.0M+876.2%	$21.0M+119.4%	-$108.0M-138.0%	$284.0M
Dividends Paid	$136.0M+2.3%	$133.0M-1.5%	$135.0M+0.7%	$134.0M0.0%	$134.0M0.0%	$134.0M+39.6%	$96.0M+540.0%	$15.0M
Share Buybacks	N/A	N/A	$82.0M	$0	$0	$0-100.0%	$17.0M	$0

LINE Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

LINE annual financial ratios

Metric	FY25	FY24	FY23	FY22
Gross Margin	32.1%-0.9pp	33.0%+0.2pp	32.8%+3.3pp	29.5%
Operating Margin	3.4%+10.1pp	-6.8%-14.2pp	7.4%+1.4pp	6.0%
Net Margin	-2.1%+11.9pp	-14.1%-12.6pp	-1.4%-0.2pp	-1.3%
Return on Equity	-1.4%+7.3pp	-8.7%-7.2pp	-1.5%-0.4pp	-1.1%
Return on Assets	-0.6%+3.4pp	-4.0%-3.6pp	-0.4%	N/A
Current Ratio	0.80-0.1x	0.86-0.1x	0.92	N/A
Debt-to-Equity	0.74+0.2x	0.57-1.2x	1.77	N/A
FCF Margin	3.7%+3.4pp	0.2%-0.3pp	0.6%+6.9pp	-6.3%

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	31.2%-0.9pp	32.1%0.0pp	32.2%-0.1pp	32.3%+0.5pp	31.9%-0.4pp	32.2%-0.1pp	32.3%-0.5pp	32.8%
Operating Margin	4.0%+1.2pp	2.8%-2.2pp	5.0%+2.5pp	2.5%+0.8pp	1.7%-2.6pp	4.3%+5.9pp	-1.6%+37.0pp	-38.6%
Net Margin	-2.1%+1.4pp	-3.5%-3.0pp	-0.5%+6.7pp	-7.3%-6.8pp	-0.4%-0.4pp	0.0%+11.8pp	-11.8%+24.5pp	-36.3%
Return on Equity	-0.4%+0.2pp	-0.6%-0.5pp	-0.1%+1.1pp	-1.2%-1.1pp	-0.1%-0.1pp	0.0%+1.8pp	-1.8%+3.5pp	-5.4%
Return on Assets	-0.1%+0.1pp	-0.2%-0.2pp	0.0%+0.5pp	-0.5%-0.5pp	0.0%0.0pp	0.0%+0.9pp	-0.9%+1.7pp	-2.5%
Current Ratio	0.78-0.1x	0.850.0x	0.80-0.2x	0.990.0x	0.960.0x	0.99+0.1x	0.86-0.2x	1.07
Debt-to-Equity	0.790.0x	0.770.0x	0.740.0x	0.710.0x	0.66+0.1x	0.600.0x	0.570.0x	0.55
FCF Margin	13.7%+17.9pp	-4.2%-10.1pp	5.8%+3.3pp	2.5%-4.5pp	7.0%+8.0pp	-0.9%-4.8pp	3.9%+1.4pp	2.5%

Note: The current ratio is below 1.0 (0.80), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Rexford Indl Rlty Inc REXR

$8.3B

CubeSmart CUBE

$9.2B

Eastgroup Pptys Inc EGP

$10.8B

First Indl Rlty Tr Inc FR

$8.3B

Public Storage PSA

$60.2B

Where LINEAGE INC Ranks

Frequently Asked Questions

What is LINEAGE INC's annual revenue?

LINEAGE INC (LINE) reported $5.4B in total revenue for fiscal year 2025. This represents a 0.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is LINEAGE INC's revenue growing?

LINEAGE INC (LINE) revenue grew by 0.3% year-over-year, from $5.3B to $5.4B in fiscal year 2025.

Is LINEAGE INC profitable?

No, LINEAGE INC (LINE) reported a net income of -$113.0M in fiscal year 2025, with a net profit margin of -2.1%.

What is LINEAGE INC's EBITDA?

LINEAGE INC (LINE) had EBITDA of $1.1B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does LINEAGE INC have?

As of fiscal year 2025, LINEAGE INC (LINE) had $66.0M in cash and equivalents against $6.1B in long-term debt.

What is LINEAGE INC's gross margin?

LINEAGE INC (LINE) had a gross margin of 32.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is LINEAGE INC's operating margin?

LINEAGE INC (LINE) had an operating margin of 3.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is LINEAGE INC's net profit margin?

LINEAGE INC (LINE) had a net profit margin of -2.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does LINEAGE INC pay dividends?

Yes, LINEAGE INC (LINE) paid $2.11 per share in dividends during fiscal year 2025.

What is LINEAGE INC's return on equity (ROE)?

LINEAGE INC (LINE) has a return on equity of -1.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is LINEAGE INC's free cash flow?

LINEAGE INC (LINE) generated $196.0M in free cash flow during fiscal year 2025. This represents a 1533.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is LINEAGE INC's operating cash flow?

LINEAGE INC (LINE) generated $943.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are LINEAGE INC's total assets?

LINEAGE INC (LINE) had $19.2B in total assets as of fiscal year 2025, including both current and long-term assets.

What are LINEAGE INC's capital expenditures?

LINEAGE INC (LINE) invested $747.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does LINEAGE INC buy back shares?

Yes, LINEAGE INC (LINE) spent $82.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does LINEAGE INC have outstanding?

LINEAGE INC (LINE) had 227M shares outstanding as of fiscal year 2025.

What is LINEAGE INC's current ratio?

LINEAGE INC (LINE) had a current ratio of 0.80 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is LINEAGE INC's debt-to-equity ratio?

LINEAGE INC (LINE) had a debt-to-equity ratio of 0.74 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is LINEAGE INC's return on assets (ROA)?

LINEAGE INC (LINE) had a return on assets of -0.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is LINEAGE INC's Altman Z-Score?

LINEAGE INC (LINE) has an Altman Z-Score of 0.68, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is LINEAGE INC's Piotroski F-Score?

LINEAGE INC (LINE) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are LINEAGE INC's earnings high quality?

LINEAGE INC (LINE) reported a net loss of $113.0M while generating $943.0M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can LINEAGE INC cover its interest payments?

LINEAGE INC (LINE) has an interest coverage ratio of 0.71x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is LINEAGE INC?

LINEAGE INC (LINE) scores 36 out of 100 on our Financial Health Score, indicating weak standing within its REITs peer group. The score is a 0-100 composite of six dimensions (FFO Margin, FFO Growth, Leverage, Interest Cov., AFFO Margin, Dividend Cov.), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.